Preventive effects of prenatal administration of OM ‐85/ BV on asthma and respiratory infection risk in the offspring: A review of animal models
Pediatric Allergy and Immunology · 2024
DOI: 10.1111/pai.14184 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Pediatric Allergy and Immunology, 2024. Verfasst von Signe Hahn Rahbek-Hansen und 5 weiteren Autor:innen. Beteiligte Einrichtung: Copenhagen Prospective Studies on Asthma in Childhood, Health Sciences, Danish Pediatric Asthma Center, Copenhagen University Hospital, University of…. Hauptthemen laut MEDLINE: Asthma, Respiratory Tract Infections, Disease Models, Animal, Prenatal Exposure Delayed Effects. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 45 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Asthma is the most common chronic disease in childhood affecting the daily lives of many patients despite current treatment regimens. Therefore, the need for new therapeutic approaches is evident, where a primary prevention strategy is the ultimate goal. Studies of children born to mothers in farming environments have shown a lower risk of respiratory infections and asthma development. Already at birth, these newborns have demonstrated accelerated maturation and upregulation of host defense immune functions suggesting a prenatal transplacental training of the innate immune system through maternal microbial exposure. This mechanism could possibly be utilized to help prevent both respiratory infections and asthma in young children. Human studies exploring the potential preventative effects of pregnancy bacterial lysate treatment on asthma and respiratory infections are lacking, however, this has been studied in experimental studies using mice through administrations of the bacterial lysate OM‐85. This review will present the current literature on the immunomodulatory effects relevant for respiratory infections and asthma in the offspring of mice treated with OM‐85 throughout pregnancy. Further, the review will discuss the cellular and molecular mechanisms behind these effects. In conclusion, we found promising results of an accelerated immune competence and improved resistance to airway challenges as a result of prenatal bacterial lysate treatment that may pave the way for implementing this in human trials to prevent asthma and respiratory infections.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Copenhagen Prospective Studies on Asthma in Childhood, Health Sciences, Danish Pediatric Asthma Center, Copenhagen University Hospital, University of Copenhagen, Gentofte, Denmark.
ORCID-Profile: Jakob Stokholm, Bo L Chawes, Nicklas Brustad
Zitieren
APA
Rahbek-Hansen, S. H., Mikkelsen, M., Stokholm, J., Bønnelykke, K., Chawes, B. L., & Brustad, N. (2024). Preventive effects of prenatal administration of OM ‐85/ BV on asthma and respiratory infection risk in the offspring: A review of animal models. Pediatric Allergy and Immunology. https://doi.org/10.1111/pai.14184
Vancouver
Rahbek-Hansen SH, Mikkelsen M, Stokholm J, Bønnelykke K, Chawes BL, Brustad N. Preventive effects of prenatal administration of OM ‐85/ BV on asthma and respiratory infection risk in the offspring: A review of animal models. Pediatric Allergy and Immunology. 2024. doi:10.1111/pai.14184
BibTeX
@article{RahbekHansen2024,
author = {Rahbek-Hansen, Signe Hahn and Mikkelsen, Marianne and Stokholm, Jakob and Bønnelykke, Klaus and Chawes, Bo L and Brustad, Nicklas},
title = {Preventive effects of prenatal administration of OM ‐85/ BV on asthma and respiratory infection risk in the offspring: A review of animal models},
journal = {Pediatric Allergy and Immunology},
year = {2024},
doi = {10.1111/pai.14184}
}
EUVIMED